Body weight remains a primary outcome measure, with different continuation criteria depending on the indication
Morning administration on an empty stomach is preferred because AOD-9604 promotes fat mobilization, and morning dosing allows fat to be utilized as fuel during daytime activity
PMID: Summary Keywords Crohns disease, GLP, GLP-1, GLP-2 receptor agonist, IBD - inflammatory bowel disease, ulcerative colitis Citation Lee JJ, Bajgain P and Lightner AL (2026) GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity
Start your medically guided weight loss journey today
Whether you are seriously considering MEDVi or just beginning to explore your options, this review will give you the information you need to decide with confidence
The region holds a 5.20% share of the global market